MTOR and neoplasm: We demonstrated that both GSK2126458 and rapamycin had anti-tumour efficacy by suppressing proliferation of tumour cells but suppression by rapamycin was much stronger than by GSK2126458, probably due to its inhibition of both mTOR and Erk/1/2 activities.